Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 3
1986 2
1987 4
1988 3
1989 2
1990 3
1991 9
1992 1
1993 1
1994 3
1995 2
1996 4
1997 3
1998 7
1999 5
2000 5
2001 8
2002 4
2003 10
2004 7
2005 3
2006 7
2007 2
2008 6
2009 6
2010 6
2011 4
2012 5
2013 6
2014 4
2015 4
2016 5
2017 10
2018 8
2019 2
2020 3
2021 6
2022 7
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Clonal evolution during metastatic spread in high-risk neuroblastoma.
Gundem G, Levine MF, Roberts SS, Cheung IY, Medina-Martínez JS, Feng Y, Arango-Ossa JE, Chadoutaud L, Rita M, Asimomitis G, Zhou J, You D, Bouvier N, Spitzer B, Solit DB, Dela Cruz F, LaQuaglia MP, Kushner BH, Modak S, Shukla N, Iacobuzio-Donahue CA, Kung AL, Cheung NV, Papaemmanuil E. Gundem G, et al. Among authors: kushner bh. Nat Genet. 2023 Jun;55(6):1022-1033. doi: 10.1038/s41588-023-01395-x. Epub 2023 May 11. Nat Genet. 2023. PMID: 37169874
Neuroblastoma.
Kushner BH, Cheung NK. Kushner BH, et al. Pediatr Ann. 1988 Apr;17(4):269-76, 278-84. doi: 10.3928/0090-4481-19880401-07. Pediatr Ann. 1988. PMID: 3290814 Review.
Re-thinking transplant for neuroblastoma.
Kushner BH. Kushner BH. Pediatr Blood Cancer. 2021 Jun;68(6):e28961. doi: 10.1002/pbc.28961. Epub 2021 Mar 4. Pediatr Blood Cancer. 2021. PMID: 33661565 No abstract available.
Chronic neuroblastoma.
Kushner BH, Kramer K, Cheung NK. Kushner BH, et al. Cancer. 2002 Sep 15;95(6):1366-75. doi: 10.1002/cncr.10800. Cancer. 2002. PMID: 12216106 Free article.
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
Kramer K, Pandit-Taskar N, Kushner BH, Zanzonico P, Humm JL, Tomlinson U, Donzelli M, Wolden SL, Haque S, Dunkel I, Souweidane MM, Greenfield JP, Tickoo S, Lewis JS, Lyashchenko SK, Carrasquillo JA, Chu B, Horan C, Larson SM, Cheung NV, Modak S. Kramer K, et al. Among authors: kushner bh. J Hematol Oncol. 2022 Nov 12;15(1):165. doi: 10.1186/s13045-022-01383-4. J Hematol Oncol. 2022. PMID: 36371226 Free PMC article. Clinical Trial.
Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events.
Mora J, Chan GC, Morgenstern DA, Nysom K, Bear MK, Tornøe K, Kushner BH. Mora J, et al. Among authors: kushner bh. Cancer Rep (Hoboken). 2023 Jan;6(1):e1627. doi: 10.1002/cnr2.1627. Epub 2022 May 17. Cancer Rep (Hoboken). 2023. PMID: 35579862 Free PMC article. Review.
Chemoimmunotherapy for high-risk neuroblastoma.
Kushner BH. Kushner BH. Lancet Oncol. 2017 Jul;18(7):845-846. doi: 10.1016/S1470-2045(17)30337-6. Epub 2017 May 23. Lancet Oncol. 2017. PMID: 28549784 No abstract available.
174 results